Earnings Scheduled For October 28, 2013

Armstrong World Industries

AWI

is expected to report its Q3 earnings at $0.86 per share on revenue of $744.17 million. Apple

AAPL

is projected to post its Q4 earnings at $7.93 per share on revenue of $36.84 billion. Merck & Co

MRK

is estimated to report its Q3 earnings at $0.88 per share on revenue of $11.12 billion. Reinsurance Group of America

RGA

is expected to post its Q3 earnings at $1.84 per share on revenue of $2.45 billion. CNA Financial

CNA

is projected to report its Q3 earnings at $0.76 per share on revenue of $2.31 billion. Biogen Idec

BIIB

is estimated to report its Q3 earnings at $2.10 per share on revenue of $1.78 billion. Tenneco

TEN

is projected to report its Q3 earnings at $0.94 per share on revenue of $1.94 billion. Kirby

KEX

is expected to report its Q3 earnings at $1.12 per share on revenue of $573.18 million. Regal Beloit

RBC

is projected to post its Q3 earnings at $1.13 per share on revenue of $771.70 million. Titan International

TWI

is expected to post its Q3 earnings at $0.25 per share on revenue of $533.99 million. Masco

MAS

is estimated to post its Q3 earnings at $0.25 per share on revenue of $2.10 billion. Seagate Technology Public Limited Company

STX

is expected to post its Q1 earnings at $1.30 per share on revenue of $3.56 billion. Roper Industries

ROP

is projected to report its Q3 earnings at $1.45 per share on revenue of $862.54 million. FMC

FMC

is expected to post its Q3 earnings at $0.83 per share on revenue of $959.47 million. Jones Lang LaSalle

JLL

is projected to post its Q3 earnings at $1.34 per share on revenue of $1.01 billion. Loews

is estimated to report its Q3 earnings at $0.77 per share. Crane Co

is expected to post its Q3 earnings at $1.06 per share on revenue of $662.88 million. Burger King Worldwide

BKW

is projected to report its Q3 earnings at $0.21 per share on revenue of $266.59 million. Herbalife

HLF

is expected to post its Q3 earnings at $1.14 per share on revenue of $1.19 billion. Edwards Lifesciences

is estimated to post its Q3 earnings at $0.66 per share on revenue of $491.18 million.

Market News and Data brought to you by Benzinga APIs

-

-

-

-

-

-

-

25% Off Benzinga's Most Powerful Trading Tools

-

-

-

-

-

-

-